4-(4-((3-(4-(3-(4-methylpiperazin-1-yl)propoxy)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)phenoxy)benzonitrile

ID: ALA3764354

Chembl Id: CHEMBL3764354

PubChem CID: 71656005

Max Phase: Preclinical

Molecular Formula: C31H30N4O3S2

Molecular Weight: 570.74

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(C#N)cc5)cc4)SC3=S)cc2)CC1

Standard InChI:  InChI=1S/C31H30N4O3S2/c1-33-16-18-34(19-17-33)15-2-20-37-26-13-7-25(8-14-26)35-30(36)29(40-31(35)39)21-23-3-9-27(10-4-23)38-28-11-5-24(22-32)6-12-28/h3-14,21H,2,15-20H2,1H3/b29-21-

Standard InChI Key:  JXHRDCVCWWSSDS-ANYBSYGZSA-N

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ikbkb Inhibitor of nuclear factor kappa-B kinase subunit beta (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 570.74Molecular Weight (Monoisotopic): 570.1759AlogP: 5.77#Rotatable Bonds: 9
Polar Surface Area: 69.04Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 5.75CX LogD: 4.96
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.18Np Likeness Score: -1.63

References

1. Kim D, Kim YG, Seo JH, Shin KJ..  (2016)  Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor.,  26  (4): [PMID:26826731] [10.1016/j.bmcl.2016.01.065]

Source